Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients

Fibroblast growth factor 21 (FGF21) is identified as a potential biomarker for liver diseases. However, information is limited regarding serum FGF21 and impaired liver function in hyperthyroidism. We aim to determine the potential association of serum FGF21 levels with impaired liver enzymes in hype...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Endocrinol (Lausanne)
Hauptverfasser: Xiao, Fangsen, Zeng, Jinyang, Huang, Peiying, Yan, Bing, Zeng, Xin, Liu, Changqin, Shi, Xiulin, Wang, Liying, Song, Haiqu, Lin, Mingzhu, Yang, Shuyu, Li, Zhibin, Li, Xuejun, Liu, Chao
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019
Schlagworte:
Endocrinology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6339876/
https://ncbi.nlm.nih.gov/pubmed/30692965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00800
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge